Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT07798167

Tuberculosis Sentinel Research Network (TB-SRN)

Conditions: TO ACCESS THE INDIVIDUAL-LEVEL EFFECTS OF HIV AND ANTIRETROVIRAL THERAPY

Sex: All
Ages: 15 Years – 99 Years
Healthy volunteers: No
Enrollment: 374
Sponsor: Centre for Infectious Disease Research in Zambia

Location: Chawama and Kanyama General Hospitals Lusaka Lusaka Province

Summary

The overarching objective/aim of the study is to assess pulmonary TB treatment and longer-term outcomes among people with and without HIV in African population in order to inform policy and practice around TB treatment and create a platform for additional TB research in Zambia

Eligibility Criteria

Inclusion Criteria: * 1\. Be ≥15 years of age * Clinically diagnosed pulmonary TB and initiated/to be initiated on anti-TB treatment, as determined by medical providers through standard of care, on the basis of either. * Microbiologically confirmed pulmonary TB based on sputum or other respiratory samples with either Exclusion Criteria: * Have plans to follow-up for TB care at a site distant from the enrollment site, imminent plans to move from his/her current area of residence, or plans to return to a distant area of residence, which would interfere with the participant's ability to complete all study visits (through the 12-month post-treatment visit). * 1\. Received \>1 week of TB treatment within the prior 30 days, excluding TB preventive therapy * 3\. Have substantial cognitive impairment that in the opinion of the site investigator or designee may interfere with the ability to give reliable informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07798167). StuddyBuddy aggregates publicly available trial information.